Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381327193> ?p ?o ?g. }
- W4381327193 endingPage "1442" @default.
- W4381327193 startingPage "1432" @default.
- W4381327193 abstract "Observational and preclinical data suggest metformin may prevent severe coronavirus disease 2019 (COVID-19) outcomes.We conducted a systematic review of randomized, placebo-controlled clinical trials of metformin treatment for COVID-19 to determine whether metformin affects clinical or laboratory outcomes in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and present a structured summary of preclinical data.Two independent reviewers searched PubMed, Scopus, Cochrane COVID-19 Study Register, and ClinicalTrials.gov on 1 February 2023 with no date restrictions for trials where investigators randomized adults with COVID-19 to metformin versus control and assessed clinical and/or laboratory outcomes of interest. The Cochrane Risk of Bias 2 tool was used to assess bias.Two reviewers extracted data pertaining to prespecified outcomes of each interest from each included trial.The synthesis plan was developed a priori and was guided by Synthesis Without Meta-analysis (SWiM) guidelines. Summary tables and narrative synthesis were used (PROSPERO, 2022, CRD42022349896). Three randomized trials met inclusion criteria. In two of the trials investigators found that metformin improved clinical outcomes (prevented need for oxygen and prevented need for acute health care use), and in the third trial a larger portion of adults with diabetes were enrolled but results did show a direction of benefit similar to that of the other trials in the per-protocol group. In the largest trial, subjects were enrolled during the delta and omicron waves and vaccinated individuals were included. The certainty of evidence that metformin prevents health care use due to COVID-19 was moderate per Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Many preclinical studies have shown metformin to be effective against SARS-CoV-2.Limitations include inclusion of only three trials and heterogeneity between trials.Future trials will help define the role of metformin in COVID-19 treatment guidelines." @default.
- W4381327193 created "2023-06-21" @default.
- W4381327193 creator A5009702241 @default.
- W4381327193 creator A5019907813 @default.
- W4381327193 creator A5036744901 @default.
- W4381327193 creator A5055979731 @default.
- W4381327193 creator A5056759771 @default.
- W4381327193 creator A5057625565 @default.
- W4381327193 creator A5058683184 @default.
- W4381327193 creator A5084501192 @default.
- W4381327193 date "2023-06-20" @default.
- W4381327193 modified "2023-09-26" @default.
- W4381327193 title "Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2" @default.
- W4381327193 cites W1796267606 @default.
- W4381327193 cites W2137586574 @default.
- W4381327193 cites W2165010366 @default.
- W4381327193 cites W2473725818 @default.
- W4381327193 cites W2516880594 @default.
- W4381327193 cites W2970684805 @default.
- W4381327193 cites W2990648940 @default.
- W4381327193 cites W3019800544 @default.
- W4381327193 cites W3022285953 @default.
- W4381327193 cites W3086028474 @default.
- W4381327193 cites W3118615836 @default.
- W4381327193 cites W3155805951 @default.
- W4381327193 cites W3157891975 @default.
- W4381327193 cites W3171139414 @default.
- W4381327193 cites W3183437698 @default.
- W4381327193 cites W3193073519 @default.
- W4381327193 cites W3196127692 @default.
- W4381327193 cites W3204168235 @default.
- W4381327193 cites W3211675872 @default.
- W4381327193 cites W4200318858 @default.
- W4381327193 cites W4205954186 @default.
- W4381327193 cites W4205970115 @default.
- W4381327193 cites W4206346269 @default.
- W4381327193 cites W4213069893 @default.
- W4381327193 cites W4220708709 @default.
- W4381327193 cites W4226093654 @default.
- W4381327193 cites W4281291961 @default.
- W4381327193 cites W4281609471 @default.
- W4381327193 cites W4281770375 @default.
- W4381327193 cites W4281869848 @default.
- W4381327193 cites W4292148078 @default.
- W4381327193 cites W4292262037 @default.
- W4381327193 cites W4302288188 @default.
- W4381327193 cites W4309264261 @default.
- W4381327193 cites W4309551142 @default.
- W4381327193 cites W4309571466 @default.
- W4381327193 cites W4381245514 @default.
- W4381327193 cites W4381327193 @default.
- W4381327193 doi "https://doi.org/10.2337/dc22-2539" @default.
- W4381327193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37339345" @default.
- W4381327193 hasPublicationYear "2023" @default.
- W4381327193 type Work @default.
- W4381327193 citedByCount "1" @default.
- W4381327193 countsByYear W43813271932023 @default.
- W4381327193 crossrefType "journal-article" @default.
- W4381327193 hasAuthorship W4381327193A5009702241 @default.
- W4381327193 hasAuthorship W4381327193A5019907813 @default.
- W4381327193 hasAuthorship W4381327193A5036744901 @default.
- W4381327193 hasAuthorship W4381327193A5055979731 @default.
- W4381327193 hasAuthorship W4381327193A5056759771 @default.
- W4381327193 hasAuthorship W4381327193A5057625565 @default.
- W4381327193 hasAuthorship W4381327193A5058683184 @default.
- W4381327193 hasAuthorship W4381327193A5084501192 @default.
- W4381327193 hasBestOaLocation W43813271931 @default.
- W4381327193 hasConcept C126322002 @default.
- W4381327193 hasConcept C142724271 @default.
- W4381327193 hasConcept C168563851 @default.
- W4381327193 hasConcept C17744445 @default.
- W4381327193 hasConcept C177713679 @default.
- W4381327193 hasConcept C199539241 @default.
- W4381327193 hasConcept C204787440 @default.
- W4381327193 hasConcept C23131810 @default.
- W4381327193 hasConcept C27081682 @default.
- W4381327193 hasConcept C2779306644 @default.
- W4381327193 hasConcept C2779473830 @default.
- W4381327193 hasConcept C2780323712 @default.
- W4381327193 hasConcept C535046627 @default.
- W4381327193 hasConcept C71924100 @default.
- W4381327193 hasConceptScore W4381327193C126322002 @default.
- W4381327193 hasConceptScore W4381327193C142724271 @default.
- W4381327193 hasConceptScore W4381327193C168563851 @default.
- W4381327193 hasConceptScore W4381327193C17744445 @default.
- W4381327193 hasConceptScore W4381327193C177713679 @default.
- W4381327193 hasConceptScore W4381327193C199539241 @default.
- W4381327193 hasConceptScore W4381327193C204787440 @default.
- W4381327193 hasConceptScore W4381327193C23131810 @default.
- W4381327193 hasConceptScore W4381327193C27081682 @default.
- W4381327193 hasConceptScore W4381327193C2779306644 @default.
- W4381327193 hasConceptScore W4381327193C2779473830 @default.
- W4381327193 hasConceptScore W4381327193C2780323712 @default.
- W4381327193 hasConceptScore W4381327193C535046627 @default.
- W4381327193 hasConceptScore W4381327193C71924100 @default.
- W4381327193 hasFunder F4320337357 @default.
- W4381327193 hasIssue "7" @default.
- W4381327193 hasLocation W43813271931 @default.